Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy
Description
See updated study design under NCT04882735. Phase 3 efficacy and safety of AG10 compared with placebo in subjects with symptomatic Transthyretin Amyloid Polyneuropathy (ATTR-PN)